Nephrolyx

Nephrolyx offers a precise and rapid measurement of the kidney function (true GFR). We provide hospitals and laboratories with an In-Vitro Diagnostic Test and a digital platform to measure the true GFR within only a few hours. For the first time, physicians can detect renal diseases using the highest accuracy of GFR measurement and adapt an optimal treatment plan for patients. Especially nephrology, oncology, transplantation, and ICU patients can benefit from rapid and precise diagnostics. The Nephrolyx IVDx is indicated for the in-vitro quantitative determination of serum iohexol concentration and calculation of the glomerular filtration rate (GFR). The principle of...

True gfr,in-vitro diagnostic test,measurement of the true gfr within only a few hours,the highest accuracy of gfr measurement,measurement of the kidney function,rapid and precise diagnostics,nephrology,oncology,transplantation,and icu patients,quantitative determination of serum iohexol concentration,calculation of the glomerular filtration rate (gfr),ultra-high-performance-liquid chromatography using ultra-violet light,innovative technology,med tech,low component cost,enhancing the performance of the entire healthcare system,and improving treatment success for kidney patients

Nephrolyx operates in the Biotechnology research industry.

Nephrolyx's revenue is 11m - 100m

Nephrolyx has 11 - 50 employees.